Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PSIL vs ASD overlap: 17% of top holdings shared

Bottom line

How much do PSIL and ASD overlap?

17% of their top holdings overlap by weight. 4 securities appear in both funds' top 25, making up 23.5% of PSIL's assets and 12.6% of ASD's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

PSILASD
Weight overlap (top 25)17%
Shared holdings4
Weight in shared holdings23.5%12.6%
Total positions3239
Expense ratio1%0.79%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings PSIL and ASD have in common

Holding% of PSIL% of ASDOverlap
Definium Therapeutics Inc DFTX12.85%4.77%4.77%
Abbvie Inc ABBV4.14%2.72%2.72%
Johnson & Johnson JNJ3.61%2.59%2.59%
Supernus Pharmaceuticals Inc SUPN2.89%2.50%2.50%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PSIL

  1. Compass Pathways Plc — 11.45%
  2. Ataibeckley Inc — 10.47%
  3. Relmada Therapeutics Inc — 6.84%
  4. Nrx Pharmaceuticals Inc — 6.07%
  5. Neurocrine Biosciences Inc — 4.38%
  6. Cybin Inc — 4.35%
  7. Gh Research Plc — 4.31%
  8. Alkermes Plc — 4.30%
  9. Alto Neuroscience Inc — 4.20%
  10. Blackrock Treasury Trust — 3.97%
  11. Bright Minds Biosciences Inc — 3.84%
  12. Drey Inst Pref Gov Mm-m — 3.10%
  13. Neuphoria Therapeutics Inc — 2.49%
  14. Neuronetics Inc — 2.17%
  15. Quantum Biopharma Ltd — 1.66%

Only in ASD

  1. Neuren Pharmaceuticals Ltd — 3.23%
  2. LifeStance Health Group Inc — 3.04%
  3. Otsuka Holdings Co Ltd — 2.95%
  4. Acadia Healthcare Co Inc — 2.90%
  5. ACADIA Pharmaceuticals Inc — 2.89%
  6. MapLight Therapeutics Inc — 2.89%
  7. BrightSpring Health Services I — 2.70%
  8. Revvity Inc — 2.68%
  9. Bright Horizons Family Solutio — 2.65%
  10. Medicover AB — 2.63%
  11. Ipsen SA — 2.60%
  12. Sumitomo Pharma Co Ltd — 2.60%
  13. Brainsway Ltd — 2.58%
  14. Pearson PLC — 2.56%
  15. Anavex Life Sciences Corp — 2.53%

Asset mix

Asset typePSILASD
Stocks95.9%99.8%
Cash & short-term funds7.1%0.2%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryPSILASD
US57.7%56.6%
CA25.2%—
GB11.5%5.0%
JP—10.2%
IE8.6%2.5%
CH—5.0%
IL—4.9%
AU—3.2%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do PSIL and ASD overlap?
About 17% by weight. 4 securities appear in both funds' top 25 holdings; they make up 23.5% of PSIL's assets and 12.6% of ASD's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do PSIL and ASD have in common?
The largest shared holdings are Definium Therapeutics Inc, Abbvie Inc, Johnson & Johnson, Supernus Pharmaceuticals Inc.
Should I own both PSIL and ASD?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, PSIL or ASD?
ASD is broader, with 39 positions versus 32 for PSIL. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.